Precision Health Clinical Trials
Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam
Conditions: Whole Exome Sequencing; Epileptic Encephalopathy
Intervention:
Sponsors: Number 2 Children's Hospital, Ho Chi Minh City; Swiss National Science Foundation; School of Medicine - Vietnam National University at Ho Chi Minh city; University of Medicine and Pharmacy at Ho Chi Minh City; University Hospital, Geneva
Recruiting
Intervention:
Sponsors: Number 2 Children's Hospital, Ho Chi Minh City; Swiss National Science Foundation; School of Medicine - Vietnam National University at Ho Chi Minh city; University of Medicine and Pharmacy at Ho Chi Minh City; University Hospital, Geneva
Recruiting
For more information, visit the Study URL.
Genomic and Dietary Aspects in Gastric Cancer Risk
Condition: Gastric Cancer
Intervention:
Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS; University of Bologna
Not yet recruiting
Intervention:
Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS; University of Bologna
Not yet recruiting
For more information, visit the Study URL.
Translational-Omics in Aortic Stenosis (TOmAS) Biobank
Conditions: Cardiovascular Diseases; Aortic Valve Stenosis
Intervention: Other: Genetics
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Recruiting
Intervention: Other: Genetics
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Recruiting
For more information, visit the Study URL.
National Register of Actionable Mutations
Condition: Solid Tumours in Advanced Stages
Intervention:
Sponsors: Federation of Italian Cooperative Oncology Groups; Roche Pharma AG; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen, LP; Takeda; Amgen; Daiichi Sankyo, Inc.; Eli Lilly and Company; Novartis; Clinical Research Technology S.r.l.
Recruiting
Intervention:
Sponsors: Federation of Italian Cooperative Oncology Groups; Roche Pharma AG; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen, LP; Takeda; Amgen; Daiichi Sankyo, Inc.; Eli Lilly and Company; Novartis; Clinical Research Technology S.r.l.
Recruiting
For more information, visit the Study URL.
Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
Conditions: Bile Duct Adenocarcinoma; Fanconi Anemia Complementation Group Gene Mutation; Metastatic Bile Duct Carcinoma; PTEN Gene Deletion
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Olaparib
Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI)
Recruiting
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Olaparib
Sponsors: Academic and Community Cancer Research United; National Cancer Institute (NCI)
Recruiting
For more information, visit the Study URL.
Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer; Neoadjuvant Chemotherapy; Pembrolizumab; Tumor Microenvironment
Intervention: Genetic: Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
Sponsor: Samsung Medical Center
Recruiting
Intervention: Genetic: Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
Sponsor: Samsung Medical Center
Recruiting
For more information, visit the Study URL.
Clinical Presentation of Genetic Disorders in Patients Attending Genetic Outpatient Clinic of Assiut University Children Hospital
Condition: Genetic Disease Clinical Presentation in Patients Attending Genetics Outpatient Clinic of Assiut University Children Hospital
Intervention:
Sponsor: Assiut University
Not yet recruiting
Intervention:
Sponsor: Assiut University
Not yet recruiting
For more information, visit the Study URL.
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
Condition: Urothelial Carcinoma
Intervention: Diagnostic Test: Cxbladder urine test
Sponsor: Pacific Edge Limited
Not yet recruiting
Intervention: Diagnostic Test: Cxbladder urine test
Sponsor: Pacific Edge Limited
Not yet recruiting
For more information, visit the Study URL.
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
Condition: Metastatic Prostate Cancer
Interventions: Genetic: Liquid Biopsy; Genetic: Archival Tumor DNA sequencing
Sponsors: SOLTI Breast Cancer Research Group; Pfizer; AstraZeneca; Merck Sharp & Dohme LLC; Advanced Accelerator Applications; Astellas Pharma Inc; Guardant Health, Inc.
Recruiting
Interventions: Genetic: Liquid Biopsy; Genetic: Archival Tumor DNA sequencing
Sponsors: SOLTI Breast Cancer Research Group; Pfizer; AstraZeneca; Merck Sharp & Dohme LLC; Advanced Accelerator Applications; Astellas Pharma Inc; Guardant Health, Inc.
Recruiting
For more information, visit the Study URL.
Decoding the Genetic Landscape of Skeletal Diseases
Conditions: Genetic Skeletal Diseases; Skeletal Dysplasia; Molecular Causes; Skeletal Disorder
Intervention:
Sponsors: Karolinska Institutet; Karolinska University Hospital; Göteborg University
Recruiting
Intervention:
Sponsors: Karolinska Institutet; Karolinska University Hospital; Göteborg University
Recruiting
For more information, visit the Study URL.